Iridium catalyst activates chemotherapy drug directly at targeted cancer cells
Summary
Conventional chemotherapy treatments often attack not only cancer cells but also healthy tissue, leading to severe side effects such as hair loss or nausea. The team led by Dr. Thomas Ward from the Department of Chemistry and the Swiss Nanoscience Institute (SNI) at the University of Basel is therefore pursuing an approach that uses artificial metal compounds as catalysts that specifically bind to tumor cells and then convert so-called prodrugs into the active ingredient at the tumor site.
Description from Phys.
Who is covering this
-
Iridium catalyst activates chemotherapy drug directly at targeted cancer cells
Conventional chemotherapy treatments often attack not only cancer cells but also healthy tissue, leading to severe side effects such as hair loss or nausea. The team led by Dr. Thomas Ward from the Department of Chemistry and the Swiss Nanoscience Institute (SNI) at the...
Comments
Comments need JavaScript.